Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_1

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

NCT04228653
completedphase_1

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

NCT03775538
completedphase_1

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

NCT03295786

Clinical Trials (3)

Showing 3 of 3 trials
NCT04228653Phase 1

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

Unknown
NCT03775538Phase 1

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

Completed
NCT03295786Phase 1

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3